Damian Lamb

Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.

Flosonics Medical develops and operates medical software platform for the management of critically ill patients. The company was founded by Joe Eibl, Jon-Emile Kenny, Andrew Eibl, and Sachit Harish and is headquartered in Sudbury, Canada.

Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

The Health Technology Exchange provides non-dilutive project financing to the medical and assistive technology sector. The company’s programs include Health Technology Commercialization Program (HTCP), REACH Innovation Procurement program and MedTech ecosystem support activities. Its initiatives include The Harmony Project, The HTX Soft Landing Program and Medtech RISE. The company was founded in 2004 and is headquartered in Toronto, Canada.

Part of Gilead Sciences, Inc., DELEX Therapeutics, Inc. is a Canadian company that researches and develops inhalation pain treatment products for cancer patients. The private company is based in Mississauga, Canada. DELEX Therapeutics was acquired by YM BioSciences, Inc. on May 03, 2005 for $7.60 million.